by Barry Teater, NCBiotech Writer May 13, 2021 .
RESEARCH TRIANGLE PARK The North Carolina Biotechnology Center awarded 48 grants and loans totaling nearly $1.8 million to universities, bioscience companies and other entities in the third quarter of its fiscal year.
The awards, made in January, February and March, support life sciences research, technology commercialization and entrepreneurship throughout North Carolina. The funding also helps universities and companies attract follow-on funding from other sources.
Company loans
Three bioscience companies received Small Business Research Loans totaling $550,000 to advance their research, product development and commercial viability.
Alacrity Medical Innovations of Chapel Hill received $100,000 to complete prototype development and prepare for an Investigational New Drug (IND) filing with the U.S. Food and Drug Administration for a disposable, drug-device combination product that treats mild to moderate bleeding in patients
As WRAL TechWire reported last week, the new norm of remote work has led many outside companies to flock to the Triangle searching for a highly-skilled tech workforce. At the same time, the region’s existing startups are boosting the size of their workforce to meet the increased market demand for tech-enabled services.
Recognizing the heightened demand for tech talent across the Triangle area, WRAL TechWire is introducing a new weekly feature to keep our readers posted on local job and internship opportunities.
Every Monday, we will round up the latest information from the region’s top job boards, offering a breakdown of how many jobs are posted, which companies are hiring and for what positions.
DURHAM –IMMvention Therapeutix, which nearly won a pitch competition from LaunchBio this summer, has won a bigger deal with investors.
Four backers are putting just over $3.9 million into the startup that is focusing on therapies to combat inflammation, according to an SEC filing.
The mix of equity and options fell just short of the $4.4 million the company sought.
IMMvention
The 4-year-old Durham company was one of three finalists in LaunchBio’s Big Pitch competition for the most promising life science or biotech startup in the United States.
IMMvention had won the competition among Durham-area startups earlier in the summer, beating out the likes of CasTag Biosciences, PhosphoGam, Praetego, and TreeCo to advance to the national round.